Croda International Plc, a Yorkshire, U.K.-based developer of specialty chemicals, has acquired Enza Biotech AB, a research enterprise established as a spinout company from Lund University in Sweden. Enza Biotech develops next-generation renewable surfactants using carbohydrate-based chemistry. Through the acquisition, Enza Biotech’s patented technology will enhance Croda’s well-established natural and renewable product portfolio, particularly in the personal care, crop care and health care markets, offering the sustainable ingredients customers demand.
Croda acquires Enza Biotech
Company News, Industry News, News | August 24, 2017 | By: ATA
You might also like...
President Trump announces tariff plans for Canada and Mexico
Ekoten Textile invests in KARL MAYER tricot machines
METAG and SYMTECH partner to serve U.S. and Canadian markets
U.S. CBP proposes new rule to strengthen enforcement, limit duty exemption for low-value shipments